Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > RATbar the liar

<< Previous

Bullboard Posts

Next >>

Comment by themagicboxon Sep 30, 2021 10:24am

71 Views

Post# 33943163

RE:RE:RATbar the liar

Its over rarbar. You post a pic of a car with your name on it but not your shares. You're embarassing yourself now.

For the record, I never post pics in a public forum. Exif data can be extracted and geo locate anyone. But you definitely are an immature brat.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland